US EditionQuebec Specialist Says mRNA Flu Vaccine Seems Increasingly Likely
4 Articles
4 Articles
Quebec specialist says mRNA flu vaccine seems increasingly likely
A flu vaccine that harnesses the messenger RNA technology that ended the COVID-19 pandemic appears increasingly likely, according to a study published in the prestigious New England Journal of Medicine. The results of a phase III clinical trial demonstrate similar or superior efficacy of this vaccine compared to traditional vaccines. However, the mRNA vaccine caused […]
An influenza vaccine that exploits messenger RNA technology that has ended the VOCID-19 pandemic seems increasingly likely, demonstrates a study published by the prestigious New England Journal of Medicine.
Two new influenza vaccines, intended for the over 65s, are being marketed this year, presented as more protective for this population. The availability of these new products sheds light on the lack of effectiveness of standard vaccines without, however, completely addressing the problem.
An influenza vaccine that exploits messenger RNA technology that has ended the VOCID-19 pandemic seems to be increasingly likely, demonstrates a study published by the prestigious New England Journal of Medicine.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
